The global cosmetic surgery market was estimated to be USD 50.79 billion in 2023 and is expected to reach at USD 142.32 billion by 2034 with a CAGR of 9.82% during the forecast period 2024-2034. Growing concern about appearance, increasing prevalence of skin-related issues, heightened demand for home-based skincare products, surge in medical tourism, escalating preference for non-invasive treatments, rising focus on novel product development, growing regulatory approvals, and increasing introduction of innovative devices for cosmetic procedures are some of the key factors boosting the market growth.
Increasing introduction of innovative devices for cosmetic procedures is predicted to boost the market growth during the forecast period. Cosmetic surgery is a voluntary procedure undertaken to enhance the physical appearance of individuals through body reshaping, contouring, and aesthetic improvement. It encompasses a distinctive blend of surgical and non-surgical methods directed towards enhancing an individual's appearance. Various types of cosmetic surgical procedures include breast augmentation, rhinoplasty (alteration of the nose), liposuction, facelifts, and eyelid surgery (blepharoplasty). For instance, in March 2023, Galderma unveiled an inventive visualization tool called FACE by Galderma, utilizing augmented reality technology to simulate real-time results.
By procedure, surgical procedures was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to the rising desire for surgical interventions such as breast augmentation, liposuction, & similar procedures, growing endorsement of aesthetic devices by regulatory agencies, and upsurge in the introduction of innovative technologies. For instance, in October 2023, Fit:match.ai. and The Marena Group joined forces to introduce a 3D body-scanning technology driven by artificial intelligence. This platform was developed to aid plastic surgeons in precisely determining the appropriate size and type of post-operative garment for their patients, ensuring the best possible recovery outcomes. Additionally, non-surgical procedure is predicted to grow at the fastest CAGR during the forecast period owing to the increasing favorability of non-invasive treatments, including dermal fillers, botulinum toxin, hyaluronic acid, and similar options. These procedures present several advantages such as quicker recovery periods, lower rates of hospitalization, painless experiences, among others.
By gender, female was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to the significant portion of the female population is opting for cosmetic procedures for diverse reasons, including skin rejuvenation & tightening, hair removal, as well as breast reduction & augmentation and rising trend in the introduction of advanced platforms. For instance, in September 2023, Cutera introduced the Secret DUO, a cutting-edge skin resurfacing and rejuvenation platform that makes use of two non-ablative fractional technologies. Additionally, male is predicted to grow at the fastest CAGR during the forecast period owing to the increase in the acceptance of cosmetic surgery among men, aimed at enhancing their aesthetic appearance and rising numbers of males opting for procedures such as gynecomastia and eyelid surgery.
By age group, 35 to 50 years was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to increase in the popularity of non-invasive procedures such as botulinum toxin among individuals within this demographic, rising awareness concerning anti-aging & body contouring treatments among women in the same age category. Additionally, 19 to 34 years is predicted to grow at the fastest CAGR during the forecast period owing to the increasing desire for cosmetic procedures among individuals in this age group, including breast augmentation & rhinoplasty, and rise in the introduction of new products. For instance, in February 2022, Merz Pharma revealed the introduction of Radiesse + Lidocaine injectable implant, designed for deep injection to expand soft tissue and enhance the appearance of moderate-to-severe jawline loss in adults aged 21 and above.
By provider, hospitals & specialty clinics was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to the increase in the volume of cosmetic procedures being carried out in both hospitals & specialized clinics, rising preference for minimally invasive treatments & shift towards specialty clinics by patients, and uptick in regulatory approvals. For instance, in May 2022, Apyx Medical declared that it obtained 510(k) clearance from the U.S. FDA to utilize its Renuvion Dermal Handpiece for certain dermal resurfacing procedures. Additionally, spas & cosmetic surgery centers is predicted to grow at the fastest CAGR during the forecast period owing to the surge in medical tourism, the emergence of new medical spas & cosmetic surgery centers, and increase in the number of procedures conducted at cosmetic centers.
North America region is anticipated for the highest revenue share during the forecast period owing to a prevalence of extensively skilled plastic surgeons conducting diverse cosmetic procedures, increasing quantity of aesthetic clinics, high acceptance of state-of-the-art aesthetic devices, and surge in the introduction of novel products. For instance, in August 2023, TELA Bio, Inc. introduced the OviTex PRS Long-Term Resorbable product to the U.S. market, suitable for plastic and reconstructive surgeries. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in non-invasive procedures, the emergence of new medical spas, a growing demand for medical tourism, and the acceptance of innovative techniques in various aesthetic clinics, a trend towards providing patients with cosmetic procedures at affordable prices, and increase in regulatory approvals. For instance, in July 2022, BIOPLUS CO. LTD disclosed that two variants of its hyaluronic acid fillers, named DeneB and Skin Plus HYAL Implant, obtained a special import license from China.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increasing introduction of innovative devices for cosmetic procedures is predicted to boost the market growth during the forecast period. Cosmetic surgery is a voluntary procedure undertaken to enhance the physical appearance of individuals through body reshaping, contouring, and aesthetic improvement. It encompasses a distinctive blend of surgical and non-surgical methods directed towards enhancing an individual's appearance. Various types of cosmetic surgical procedures include breast augmentation, rhinoplasty (alteration of the nose), liposuction, facelifts, and eyelid surgery (blepharoplasty). For instance, in March 2023, Galderma unveiled an inventive visualization tool called FACE by Galderma, utilizing augmented reality technology to simulate real-time results.
By procedure, surgical procedures was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to the rising desire for surgical interventions such as breast augmentation, liposuction, & similar procedures, growing endorsement of aesthetic devices by regulatory agencies, and upsurge in the introduction of innovative technologies. For instance, in October 2023, Fit:match.ai. and The Marena Group joined forces to introduce a 3D body-scanning technology driven by artificial intelligence. This platform was developed to aid plastic surgeons in precisely determining the appropriate size and type of post-operative garment for their patients, ensuring the best possible recovery outcomes. Additionally, non-surgical procedure is predicted to grow at the fastest CAGR during the forecast period owing to the increasing favorability of non-invasive treatments, including dermal fillers, botulinum toxin, hyaluronic acid, and similar options. These procedures present several advantages such as quicker recovery periods, lower rates of hospitalization, painless experiences, among others.
By gender, female was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to the significant portion of the female population is opting for cosmetic procedures for diverse reasons, including skin rejuvenation & tightening, hair removal, as well as breast reduction & augmentation and rising trend in the introduction of advanced platforms. For instance, in September 2023, Cutera introduced the Secret DUO, a cutting-edge skin resurfacing and rejuvenation platform that makes use of two non-ablative fractional technologies. Additionally, male is predicted to grow at the fastest CAGR during the forecast period owing to the increase in the acceptance of cosmetic surgery among men, aimed at enhancing their aesthetic appearance and rising numbers of males opting for procedures such as gynecomastia and eyelid surgery.
By age group, 35 to 50 years was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to increase in the popularity of non-invasive procedures such as botulinum toxin among individuals within this demographic, rising awareness concerning anti-aging & body contouring treatments among women in the same age category. Additionally, 19 to 34 years is predicted to grow at the fastest CAGR during the forecast period owing to the increasing desire for cosmetic procedures among individuals in this age group, including breast augmentation & rhinoplasty, and rise in the introduction of new products. For instance, in February 2022, Merz Pharma revealed the introduction of Radiesse + Lidocaine injectable implant, designed for deep injection to expand soft tissue and enhance the appearance of moderate-to-severe jawline loss in adults aged 21 and above.
By provider, hospitals & specialty clinics was the highest revenue-grossing segment in the global cosmetic surgery market in 2023 owing to the increase in the volume of cosmetic procedures being carried out in both hospitals & specialized clinics, rising preference for minimally invasive treatments & shift towards specialty clinics by patients, and uptick in regulatory approvals. For instance, in May 2022, Apyx Medical declared that it obtained 510(k) clearance from the U.S. FDA to utilize its Renuvion Dermal Handpiece for certain dermal resurfacing procedures. Additionally, spas & cosmetic surgery centers is predicted to grow at the fastest CAGR during the forecast period owing to the surge in medical tourism, the emergence of new medical spas & cosmetic surgery centers, and increase in the number of procedures conducted at cosmetic centers.
North America region is anticipated for the highest revenue share during the forecast period owing to a prevalence of extensively skilled plastic surgeons conducting diverse cosmetic procedures, increasing quantity of aesthetic clinics, high acceptance of state-of-the-art aesthetic devices, and surge in the introduction of novel products. For instance, in August 2023, TELA Bio, Inc. introduced the OviTex PRS Long-Term Resorbable product to the U.S. market, suitable for plastic and reconstructive surgeries. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in non-invasive procedures, the emergence of new medical spas, a growing demand for medical tourism, and the acceptance of innovative techniques in various aesthetic clinics, a trend towards providing patients with cosmetic procedures at affordable prices, and increase in regulatory approvals. For instance, in July 2022, BIOPLUS CO. LTD disclosed that two variants of its hyaluronic acid fillers, named DeneB and Skin Plus HYAL Implant, obtained a special import license from China.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Procedure, Gender, Age Group, and Provider
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Cosmetic Surgery Market Report 2023 - 2034
Cosmetic Surgery Market Analysis & Forecast by Procedure 2023 - 2034 (Revenue USD Bn)
- Non-Surgical Procedures
- Surgical Procedures
Cosmetic Surgery Market Analysis & Forecast by Gender 2023 - 2034 (Revenue USD Bn)
- Male
- Female
Cosmetic Surgery Market Analysis & Forecast by Age Group 2023 - 2034 (Revenue USD Bn)
- 18 Years & Younger
- 19 To 34 Years
- 35 To 50 Years
- 51 To 64 Years
- 65 Years & Above
Cosmetic Surgery Market Analysis & Forecast by Provider 2023 - 2034 (Revenue USD Bn)
- Spas & Cosmetic Surgery Centers
- Hospitals & Specialty Clinics
Cosmetic Surgery Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Cosmetic Surgery Market: Procedure Estimates & Trend Analysis
8. Cosmetic Surgery Market: Gender Estimates & Trend Analysis
9. Cosmetic Surgery Market: Age Group Estimates & Trend Analysis
10. Cosmetic Surgery Market: Provider Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Cosmetic Surgery Market
13. Europe Global Cosmetic Surgery Market
14. Asia Pacific Global Cosmetic Surgery Market
15. Latin America Global Cosmetic Surgery Market
16. MEA Global Cosmetic Surgery Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Apyx Medical
- Sientra Inc.
- Cutera
- GALDERMA
- Johnson & Johnson Services Inc.
- Cynosure
- AbbVie Inc
- Bausch Health Companies Inc.
- Merz Pharma
- Long Island Plastic Surgical Group
